Should I Buy BV? BV 2026 Analysis

Should You Buy Brightview Holdings Inc (BV) Today? Analysis, Price Targets, and 2026 Outlook.

Conclusion

Hold

Latest Price

13.550

1 Day change

4.88%

52 Week Range

17.110

Analysis Updated At

2026/02/04

Should I buy Analysis is updated weekly. For real time "Should I Buy" analysis, please sign up to get free answers.

Not a good buy right now at ~13.92 pre-market: price is pressing into near-term resistance (R1 13.80 / R2 14.01) with options positioning skewed defensive/bearish.
Near-term momentum is improving (positive/expanding MACD), but the setup looks more like a “buy the pullback” than “chase the breakout” given resistance overhead and a weak 1-month statistical outlook (-6.46%).
Intellectia Proprietary Trading Signals
- AI Stock Picker: No signal on given stock today.
- SwingMax: No signal on given stock recently.

Technical Analysis

Trend/Momentum: MACD histogram is positive (0.0332) and expanding → bullish momentum building.
RSI: RSI(6) at ~65.3 → bullish-leaning but nearing short-term overbought; upside may be limited without a pause.
Moving averages: converging → transition phase; breakouts can fail more often when MAs haven’t clearly stacked bullish yet.
Levels: Pivot 13.452; Support S1 13.106 (then S2 12.893). Resistance R1 13.798 and R2 14.011. With pre-market ~13.92, the stock is already above R1 and close to R2 → poorer risk/reward for an impatient entry.
Pattern-based outlook: similar-pattern stats imply muted next-day move (+0.39%), slightly negative next-week (-0.19%), and materially negative next-month (-6.46%).

Options Data

Bearish

Open Interest Put-Call Ratio

Bearish

Option Volume Put-Call Ratio

Positioning/Sentiment: Put-heavy open interest (PCR 2.29) + put-leaning volume (PCR 1.14) → market is hedged and leaning bearish/defensive.
Volatility: 30D IV ~95.3 vs historical vol ~27.3; IV percentile 84 → options are priced for large moves (expensive premium), typically seen around events/uncertainty.
Flow intensity: today’s option volume is ~750% of 30-day average → elevated attention, but skew suggests caution rather than aggressive upside speculation.

Technical Summary

Sell

Buy

Positive Catalysts

- Earnings-related catalyst: revenue beat (Q1 revenue $614.7M) and adjusted EBITDA improved to $53.5M.
- Guidance: reaffirmed FY2026 total revenue guidance ($2.67B–$2.73B), which can stabilize expectations.
- Technical momentum: positive/expanding MACD supports a continued push higher if 14.01 breaks and holds.

Neutral/Negative Catalysts

- Profitability pressure: net loss widened (net income -$15.2M) and gross margin fell to 17.59% (down YoY).
- Options market tone is defensive: heavy put open interest and put-leaning volume can act as a headwind for chasing strength.
- Overhead resistance nearby (14.01 area) increases the chance of a near-term stall/pullback after the pre-market pop.

Financial Performance

Latest quarter: 2026/Q1.
Growth: Revenue $614.7M, +2.59% YoY (modest top-line growth).
Earnings quality: Net income -21.65% YoY to -$15.2M (loss widened), while EPS improved to -0.26 (+30% YoY) but remains negative.
Margins: Gross margin 17.59%, down 11.21% YoY → indicates cost/price mix pressure despite improved adjusted EBITDA.
Management tone: reaffirmed FY2026 revenue guidance → supportive, but margin trajectory is the key swing factor.

Growth

Profitability

Efficiency

Analyst Ratings and Price Target Trends

Recent rating/target trend is mixed: November saw notable target cuts (Morgan Stanley to $12; Goldman to $10.50 with Sell), reflecting macro headwinds and softer guidance.
More recently (Feb 2), Baird reiterated a bullish stance (Outperform) and highlighted BV as a “Fresh Pick” with a $15 target into earnings.
Wall Street pros: EBITDA improvement, reaffirmed revenue guide, and potential operational leverage if demand stabilizes.
Wall Street cons: revenue headwinds in core businesses, below-consensus guidance concerns (per prior notes), and ongoing profitability/margin pressure.
Influential/insider/political activity: Hedge funds neutral, insiders neutral; no recent Congress trading data available.

8 Analyst Rating

Wall Street analysts forecast BV stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for BV is 14.25 USD with a low forecast of 10.5 USD and a high forecast of 20 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.

5 Buy

1 Hold

2 Sell

Moderate Buy

Current: 12.920

Low

10.5

Averages

14.25

High

Current: 12.920

Low

10.5

Averages

14.25

High

JPMorgan

Andrew Steinerman

Underweight

maintain

$12 -> $13

AI Analysis

2026-02-05

New

Reason

JPMorgan

Andrew Steinerman

Price Target

$12 -> $13

AI Analysis

2026-02-05

New

maintain

Underweight

Reason

JPMorgan analyst Andrew Steinerman raised the firm's price target on BrightView to $13 from $12 and keeps an Underweight rating on the shares. The company reported inline fiscal Q1 results, the analyst tells investors in a research note.

Baird

Outperform

maintain

$15

2026-02-02

Reason

Baird

Price Target

$15

2026-02-02

maintain

Outperform

Reason

Baird designated BrightView as a bullish Fresh Pick heading into its earnings report. Baird maintains its Outperform rating and $15 price target on BrightView shares.

Unlock Full Analyst Thesis， Get the complete breakdown of rating reason for BV

Unlock Now

BV Should I Buy

BV Should I Buy

Should You Buy Brightview Holdings Inc (BV) Today? Analysis, Price Targets, and 2026 Outlook.

Technical Analysis

Options Data

Technical Summary

Positive Catalysts

Neutral/Negative Catalysts

Financial Performance

Growth

Profitability

Efficiency

Analyst Ratings and Price Target Trends

People Also Watch